Hoth Therapeutics filed two provisional patent applications with the U.S. Patent and Trademark Office, expanding the ...

Hoth Therapeutics has filed two U.S. provisional patent applications that significantly expand its intellectual property ...

Radiation has been a staple of breast cancer treatment for decades, but a new study is casting doubt on whether it is ...

Hoth Therapeutics (NASDAQ: HOTH), a clinical-stage biopharmaceutical company developing innovative therapies for underserved medical needs, today announced the filing of two U.S. provisional patent ...

Radiation therapy is a treatment that uses high-energy rays, like X-rays, gamma rays or protons, to target and destroy cancer cells. It works by damaging the DNA of cancer cells, preventing them from ...

The daughter of a top Iranian official now works as a doctor in the United States. Fatemeh Ardeshir-Larijani, whose father is ...

New research found patients with certain head and neck cancers lived longer and experienced fewer side effects when treated with proton therapy instead of traditional radiation.

In oncology, few diagnoses carry the weight of pancreatic ductal adenocarcinoma. Long characterized by its aggressive nature and silent progression, pancreatic cancer remains one of the most ...

Tukysa, combined with Herceptin and Perjeta, extends progression-free survival in HER2+ metastatic breast cancer, showing ...

Triple-positive breast cancer involves tumors positive for estrogen, progesterone, and HER2 receptors, affecting treatment decisions and strategies. Diagnosis includes imaging and biopsy to confirm ...

Investing.com -- Hoth Therapeutics Inc (NASDAQ:HOTH) stock rose 5.1% in Friday’s premarket trading after the clinical-stage biopharmaceutical company announced the filing of two U.S. provisional ...